MedRhythms
Portland · Biotechnology, Information Technology · 26 employees
MedRhythms is a digital therapeutics company that uses sensors, music and software to build evidence-based neurologic interventions to measure and improve walking. The Company’s product pipeline consists of multiple clinical programs for neurologic conditions, the most advanced are in chronic stroke, multiple sclerosis, and Parkinson’s disease. MedRhythms was founded out of Spaulding Rehabilitatio
Funding history
- Seed — $3.3M — Mar 2026
- Seed — $2.9M — Apr 2025
- Venture - Series Unknown — $19.8M — Jan 2024
- Venture - Series Unknown — $19.0M — Dec 2023
- Venture - Series Unknown — $5.8M — Feb 2023
Recent signals
- Mar 02, 2026: Raised $3.3M in Seed
- Jul 07, 2025: MedRhythms Appoints Larry Jasinski as Chief Executive Officer
- Apr 03, 2025: Raised $2.9M in Seed
- Feb 04, 2025: MedRhythms Hires Joel Behnke as Chief Commercial Officer
- Jan 16, 2025: Launched MedRhythms, Inc. Launches InTandem® Rehabilitation System for Chronic Stroke Gait Impairment, Receiving Medicare Payment Determination.
- Jan 09, 2024: Raised $19.8M in Venture - Series Unknown
- Dec 12, 2023: Raised $19.0M in Venture - Series Unknown
- Feb 22, 2023: Raised $5.8M in Venture - Series Unknown
See plans & pricing → Track MedRhythms’s funding, hiring, and signals — with verified contacts — on Fundz.